Ipca Laboratories Board approves BuyBack of Shares
Ipca Laboratories Ltd has announced that the Compensation / Remuneration Committee of the Board and that of Board of Directors of the Company at its meeting held on November 11, 2008, inter-alia, have taken the following decisions:

1. Appointment of Mr. Pranay Godha, son of Mr. Premchand Godha, Managing Director, who is currently President – APIs and Generics of the Company as the Additional Director designated as Whole-time Executive Director and remuneration payable to him;

2. Subject to necessary consents and applicable statutory provisions, buy back of Company’s own fully paid-up equity shares of Rs 10/- each from the open market using electronic trading facilities of the Stock Exchanges with outlay of maximum amount of Rs 60 crores representing less than 10% of the Company’s paid-up equity share capital and free resources at a maximum price of not over Rs 600/- per share.